References
- Puel A. Human inborn errors of immunity underlying superficial or invasive candidiasis. Hum Genet. 2020;139:1011–1022.
- Ahonen P, Myllarniemi S, Sipila I, et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322:1829–1836.
- Yan Z, Gang X, Xie X, et al. A case report and literature review. Medicine (Baltimore). 2020;99:e20000.
- Fierabracci A, Bizzarri C, Palma A, et al. A novel heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED). Gene. 2012;511:113–117.
- Kisand K, Link M, Wolff AS, et al. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood. 2008;112:2657–2666.
- Break TJ, Oikonomou V, Dutzan N, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371:252–25+.
- Orlova EM, Sozaeva LS, Kareva MA, et al. Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2017;102:3546–3556.
- Culp CJ, Pappas CM, Toso M, et al. Clinical, histological and genetic findings in a donor with a clinical history of type 1 autoimmune polyendocrinopathy syndrome. Am J Ophthalmol Case Rep. 2022;25:101266.
- Busskamp V, Picaud S, Sahel JA, et al. Optogenetic therapy for retinitis pigmentosa. Gene Ther 2012;19:169–175.
- Morizane Y, Morimoto N, Fujiwara A, et al. Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol. 2019;63:26–33.